Applied Sciences > Medicine > DG CY2020 8158

Research Title Development of Novel Nanomedicine (Redox Nanoparticles) for the Protection of Radiotherapy Patients and Nuclear Workers (Year 1 of 1)
Research Personnel Leader:
Staff:


Research Duration Start:
End:
1 August 2019
31 March 2021
Research Location PNRI
Research Description The project will develop a Novel Nanomedicine (Redox Nanoparticles) for the Protection of Radiotherapy Patients and Nuclear Workers.
Research Objectives 1. To procure, install, calibrate and dose map the X-rays irradiator; 2. To synthesize and characterize the redox nanoparticles; 3. To conduct preliminary animal trials for its (nanoparticles) radiation protective efficacy against ionizing radiation-induced reactive oxygen species (ROS); 4. To conduct in vivo radiation protection studies with the use of redox nanoparticles; 5. To determine the optimum dose required and its effective route of administration (e.g. oral); and 6. Results presentation and report writing
Research Beneficiary(ies) 1) Cancer patients; 2) Patient undergoing Radiotherapy; 3) Radiation and Nuclear Workers; 4) Availability of upgraded Radiation Biology Laboratory for researchers and research students
Research Accoplishments [CY 2019] 1) Patentable product(s): New Nanomedicine for Use in Radiotherapy & General Radiation Protection of Nuclear/Radiation Workers; 2) Papers presented in local and international conferences; 3) Published papers in ISI listed journals (at least one (1) ISI paper); 4) Established international research linkage(s); 5) Other Expected Outputs: a. Upgraded Radiation Research Center b. Trained Graduate Students/New PNRI Personnel
Total Research Cost ₱5,840,357.55
Research Agencies Funding:
Implementing:
Cooperating:
Monitoring:

PNRI


Research Budget Breakdown Year:
Year Funded:
PS:
MOOE:
EO:
Total Cost
Date Released
Amount Released








Code DG CY2020 8158
KRA Code
Priority Thrust DOST
R&D


Sector Applied Sciences
Actual Sector Medicine
Related sectors Nuclear, Nanotechnology
Entry revision: February 2021